Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Anja Geldhof"'
Autor:
Marijo Otero‐Lobato, Adesoji Adeyemo, Michelle Higley, Kathleen G. Lomax, Anja Geldhof, Suzan Esslinger
Publikováno v:
Pharmacology Research & Perspectives, Vol 12, Iss 4, Pp n/a-n/a (2024)
Abstract Data on the use of golimumab (GLM) during pregnancy are limited. This study evaluated pregnancy outcomes in women treated with GLM during pregnancy. Cumulative data on GLM‐exposed pregnancies from the Company's global safety database (GSD)
Externí odkaz:
https://doaj.org/article/09f8486643174e988a35c2cb946ca532
Autor:
Sandra Lopez-Leon, Anja Geldhof, Julie Scotto, Keele Wurst, Meritxell Sabidó, Jingping Mo, Ditte Molgaard-Nielsen, Jorieke E. H. Bergman, Xuan Anh Phi, Sue Jordan
Publikováno v:
Journal of Pregnancy, Vol 2024 (2024)
Purpose. Studies focusing on safety outcomes typically require large populations to comprehensively characterise the patient groups exposed to the medicines under investigation. However, there is often less information for subpopulations, such as pre
Externí odkaz:
https://doaj.org/article/df739165f1454c4a826e43628e41dd43
Autor:
Suzan Esslinger, Linda Quinn, Sami Sampat, Marijo Otero-Lobato, Wim Noël, Anja Geldhof, Nicole Herijgers, Sarah-Jane Reeder
Publikováno v:
Journal of Pharmaceutical Health Care and Sciences, Vol 8, Iss 1, Pp 1-15 (2022)
Abstract Introduction In the European Union (EU), a Risk Management Plan (RMP) is submitted as part of the dossier for initial marketing authorization of a medicinal product or with an application involving a significant change to an existing marketi
Externí odkaz:
https://doaj.org/article/1dfec1e1580b49d5ab6ef74bb17fea62
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Background: The golimumab safety awareness study commenced in 2010 to measure, periodically, the awareness of golimumab prescriber healthcare professionals (HCPs) of specific risks associated with golimumab as well as awareness of the requirement to
Externí odkaz:
https://doaj.org/article/fd95f2845dcc4c7d8cc77a9b5817af33
Autor:
Uma Mahadevan, Saule Naureckas, Ilia Tikhonov, Yiting Wang, Connie B. Lin, Anja Geldhof, C. Janneke van der Woude
Publikováno v:
Alimentary Pharmacology and Therapeutics, 56(3), 477-490. Wiley-Blackwell Publishing Ltd
Background: Ustekinumab, a human immunoglobulin G1 monoclonal antibody that binds to and inhibits interleukin (IL)-12/IL-23, is indicated for multiple immune-mediated diseases. Ustekinumab is actively transported across the placenta and theoretically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31b1b773d232ef580d3b2420fc6b393e
https://doi.org/10.1111/apt.16960
https://doi.org/10.1111/apt.16960
Autor:
Suzan Esslinger, Linda Quinn, Sami Sampat, Marijo Otero-Lobato, Wim Noël, Anja Geldhof, Nicole Herijgers, Sarah-Jane Reeder
Publikováno v:
Journal of pharmaceutical health care and sciences. 8(1)
Introduction In the European Union (EU), a Risk Management Plan (RMP) is submitted as part of the dossier for initial marketing authorization of a medicinal product or with an application involving a significant change to an existing marketing author
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7dcde2718b596777c170ab12bc77e4d
https://pubmed.ncbi.nlm.nih.gov/35509028
https://pubmed.ncbi.nlm.nih.gov/35509028
Publikováno v:
Journal of the American Academy of Dermatology. 83:AB74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d898f8ccd1e4e98b868c8759849251c5
https://doi.org/10.1016/j.jaad.2020.06.382
https://doi.org/10.1016/j.jaad.2020.06.382
Autor:
Anja Geldhof, Ilia Tikhonov, Sheri Volger, Colleen Marano, Christopher D. O'Brien, Connie B. Lin
Publikováno v:
Gastroenterology. 158:S-442
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d26c23ac591755a5204bd452ee32ad38
https://doi.org/10.1016/s0016-5085(20)31787-x
https://doi.org/10.1016/s0016-5085(20)31787-x
Autor:
Frank M. Ruemmele, Sibylle Koletzko, Salvatore Cucchiara, James Markowitz, Jeffrey S. Hyams, Mark R. Molenda, Anne M. Griffiths, J. Fell, Gigi Veereman, Subra Kugathasan, Jay Popp, Johanna C. Escher, Marla Dubinsky, Harland S. Winter, Richard B. Colletti, Robert N. Baldassano, Benjamin D. Gold, Anja Geldhof, Kezhen L. Tang, William A. Faubion
Publikováno v:
Gastroenterology. 146:S-456
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c05acd1c612f9ff3db9f86741b89bbab
https://doi.org/10.1016/s0016-5085(14)61634-6
https://doi.org/10.1016/s0016-5085(14)61634-6
Autor:
Jo Van Ginderachter, Yuanqing Liu, Anja Geldhof, Lea Brys, Kris Thielemans, Patrick De Baetselier, Geert Raes
Publikováno v:
Vrije Universiteit Brussel
We previously reported on a murine T lymphoma cell line, BW-Sp3, with inherent immunogenicity. BW-Sp3 tumors can elicit an anti-tumor CD8(+) CTL response capable of mediating a regression of subcutaneous tumors. However, this immune response is inade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b75d72e7b5f845a3de4d46a0093a3f27
https://biblio.vub.ac.be/vubir/b71-ifngamma-and-antictla4-cooperate-to-prevent-tcell-tolerization-during-immunotherapy-against-a-murine-tlymphoma(15fcd5f3-7788-4ada-a434-d15487498126).html
https://biblio.vub.ac.be/vubir/b71-ifngamma-and-antictla4-cooperate-to-prevent-tcell-tolerization-during-immunotherapy-against-a-murine-tlymphoma(15fcd5f3-7788-4ada-a434-d15487498126).html
